Membership Area
Forgot password?
To register place your 1st order
All our papers are  WRITTEN FROM SCRATCH
All our papers are
We do not compromise the quality of the papers delivered. At, you can trust our refund policy. If you prove that a low quality paper has been delivered, you get your money back!
100% Quality guarantee
Do you want some real proof that we can cope with your essay? The customers' reviews about our services are the most substantial evidence of our writing quality. Why don't you have a look at our testimonials and see why people come back to our website every semester?
100% Quality guarantee
All you need to do is choose the type of your future paper, set the deadline, provide us with all the necessary details regarding your paper, wait a bit, and download the final product created by our professionals.
3 main reasons why you should
  • Affordable prices.
  • Quality papers.
  • On time delivery.
100% Quality guarantee
DISCOUNTS offers 2 kinds of discount programs to customers. The first type is for the first-time customers. It allows them to save up to 15% on the first order. The second one is a fidelity program for our returning clients. It is possible to get lifetime discounts of 5%, 10%, and 15% off the original price.
100% Quality guarantee
An attractive option, which allows you to always view your demo account, is another thing which proves professionalism of our writing service. It will help you evaluate our company's performance during the working process.
← Obstacles for Studying AbroadThe Dalai Lama's Doubts →

Transnational Corporation Novo Nordisk

Buy Custom Transnational Corporation Novo Nordisk Essay

Transnational corporation Novo Nordisk A/S is the world’s biggest insulin producer. The company has a strong market position supported by constantly increasing financial indexes. Therefore, this paper analyses Novo Nordisk’s financial data and key financial indicators presented in two last financial reports for 2010 and 2011.

Financial Analysis

Novo Nordisk showed significant growth of its financial performance over the last few decades. The last two years also were successful for the company. Main financial indicators had a positive surplus in 2011 comparatively to 2010.

Novo Nordisk’s sales increased by 8% while growth profit went up by 7% in 2011. Operating profit had positive tendencies as well; it grew by 12%. To summarize, Novo Nordisk’s net profit increased by 19% in 2011 comparatively to 2010 (Novo Nordisk, 2011).

Total assets of the company and cash flow from operating activities had an increase by 3% and 18% respectively in 2011. Sales of diabetes care products grew by 6-10% for different items. Sales in biopharmaceuticals segment increased for all products by 3-12%. Total sales of the company had positive dynamics of rising by 8% in 2011 (Novo Nordisk, 2011).

Type of assignment Writer level Title of your paper Pages
Spacing Urgency Currency Total price

Novo Nordisk has been selling A shares (non-listed shares) and B shares (listed shares) in Copenhagen and on London Stock Exchange in 2010 and 2011. The stock price for a share is $146.66 on July 13, 2012 (NASDAQ, 2012). Novo Nordisk’s stock market chart for the last year shows a sharp increase in prices in February 2012 comparatively to January 2012 by approximately $20 per share. The index had been slightly growing till May of the same year. However, it decreased by $14 in June 2012 (NASDAQ, 2012). 

Thus, the tremendous increase in profits proves high development level of the company and its stable position in the market. The raise of total assets and cash flow indexes indicates the increase of Novo Nordisk’s sales operations. Novo Nordisk uses its resources in a responsible and sufficient way. Successful performance of Novo Nordisk in the market is also proved with the company’s market share. Novo Nordisk’s market share is 41-63% in different countries (Novo Nordisk, 2011). Hence, the company’s profitability and position in the market significantly improved during 2010 and 2011.


The results of researching Novo Nordisk’s business structure, strategy, management system, marketing mix, and financial analysis prove the sustainability of the company and its successful business performance. Novo Nordisk is a large business, which involves a number of employees all over the world. Its strategy and goals are thoroughly planned for a long period. The management system has a stable structure with shared responsibilities. Products, price, distribution channels, and promotion system are well developed and efficient.

The company is highly competitive, although there is a threat of tough competition from its main rivals Eli Lilly and Sanofi Aventis. The business structure of Novo Nordisk includes a well-developed system of production facilities and distribution centers.

Pharmaceutical sector grows and develops extremely fast. The profits in the pharmaceutical industry can be described as highly competitive. The number of companies in the sector increases every year. A large amount of new technologies in the pharmaceutical sector makes it profitable and increasingly innovative. Therefore, I am positive that the industry will keep evolving and growing generating higher profits in the future.

Thus, I consider the idea of working for or owning Novo Nordisk as an attractive opportunity. The company’s policy toward its employees and the general business strategy is the key reasons why I would like to become a Novo Nordisk employee. Investing money in Novo Nordisk is also an interesting possibility since the company has a reliable and stable financial situation.

The company operates in 179 countries, producing its insulin in 6 countries. Therefore, I would recommend Novo Nordisk to build extra production facilities in a few more countries in order to decrease the transportation cost. Moreover, it would allow producing insulin in bigger quantities.

Buy Custom Transnational Corporation Novo Nordisk Essay

Related essays

  1. The Dalai Lama's Doubts
  2. Transport
  3. Obstacles for Studying Abroad
  4. Danish Insulin Producer Novo Nordisk